Observational Study With NOVOCART® Inject in the Reconstruction of the Hip Joint With Full Thickness Cartilage Defects

NCT02179346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2019-12-06

No results posted yet for this study

Summary

Non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with full thickness cartilage defects in the hip.

Conditions

  • Cartilage Disease

Sponsors & Collaborators

  • Aesculap AG

    collaborator INDUSTRY
  • Tetec AG

    lead INDUSTRY

Principal Investigators

  • Klaus-Peter Guenther, Prof. MD · Universitätsklinikum Carls Gustav Carus der TU Dresden

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2018-06-30
Completion
2018-06-18

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02179346 on ClinicalTrials.gov